Matheus W. Crommentuijn
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment.
Journal: Frontiers in immunology
Published: November 23, 2023
Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy.
Journal: Journal for immunotherapy of cancer
Published: June 09, 2020
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
Journal: Nature communications
Published: June 02, 2020
Immune involvement of the contralateral hemisphere in a glioblastoma mouse model.
Journal: Journal for immunotherapy of cancer
Published: March 21, 2020
Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity.
Journal: Frontiers in immunology
Published: October 18, 2017
Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8.
Journal: Journal of extracellular vesicles
Published: August 04, 2017
A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer.
Journal: Oncotarget
Published: October 04, 2015
Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
Journal: Molecular oncology
Published: September 11, 2015
Microvesicle-associated AAV vector as a novel gene delivery system.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 09, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026